Buley I D, Gatter K C, Heryet A, Mason D Y
J Clin Pathol. 1987 Feb;40(2):136-42. doi: 10.1136/jcp.40.2.136.
A total of 67 samples from normal and pathological thyroid glands were stained (as formalin fixed paraffin sections) with a panel of monoclonal antibodies directed against intermediate filament proteins. The study confirmed previous reports of cytokeratin and vimentin coexpression in primary thyroid carcinomas, but coexpression was also detected in normal thyroid and in a range of benign conditions including follicular adenomas, Hashimoto's thyroiditis, and diffuse hyperplasia (thyrotoxicosis). Prekeratin expression was found (using antibodies recognising higher molecular weight cytokeratins) predominantly in areas of squamous change, independent of the underlying thyroid pathology. This study does not therefore support previous findings that prekeratin expression provides a reliable means of distinguishing follicular pattern papillary carcinoma from follicular carcinoma with its poorer prognosis or that it helps distinguish benign from malignant papillary lesions. No evidence of desmin or neurofilament expression was seen, and in particular, neurofilaments could not be detected in any of the cases of medullary carcinoma studied.
总共67份来自正常和病理甲状腺的样本(以福尔马林固定石蜡切片形式)用一组针对中间丝蛋白的单克隆抗体进行染色。该研究证实了先前关于原发性甲状腺癌中细胞角蛋白和波形蛋白共表达的报道,但在正常甲状腺以及一系列良性病变(包括滤泡性腺瘤、桥本甲状腺炎和弥漫性增生(甲状腺毒症))中也检测到了共表达。前角蛋白表达(使用识别高分子量细胞角蛋白的抗体)主要见于鳞状化生区域,与潜在的甲状腺病理状况无关。因此,本研究不支持先前的发现,即前角蛋白表达可作为区分滤泡型乳头状癌与预后较差的滤泡癌的可靠方法,或有助于区分良性与恶性乳头状病变。未观察到结蛋白或神经丝表达的证据,特别是在所研究的任何一例髓样癌病例中均未检测到神经丝。